298 related articles for article (PubMed ID: 22011071)
1. Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy.
Werner ME; Copp JA; Karve S; Cummings ND; Sukumar R; Li C; Napier ME; Chen RC; Cox AD; Wang AZ
ACS Nano; 2011 Nov; 5(11):8990-8. PubMed ID: 22011071
[TBL] [Abstract][Full Text] [Related]
2. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.
Hrkach J; Von Hoff D; Mukkaram Ali M; Andrianova E; Auer J; Campbell T; De Witt D; Figa M; Figueiredo M; Horhota A; Low S; McDonnell K; Peeke E; Retnarajan B; Sabnis A; Schnipper E; Song JJ; Song YH; Summa J; Tompsett D; Troiano G; Van Geen Hoven T; Wright J; LoRusso P; Kantoff PW; Bander NH; Sweeney C; Farokhzad OC; Langer R; Zale S
Sci Transl Med; 2012 Apr; 4(128):128ra39. PubMed ID: 22491949
[TBL] [Abstract][Full Text] [Related]
3. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
Farokhzad OC; Cheng J; Teply BA; Sherifi I; Jon S; Kantoff PW; Richie JP; Langer R
Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6315-20. PubMed ID: 16606824
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumor efficacy of folate targeted nanoparticles co-loaded with docetaxel and curcumin.
Hu L; Pang S; Hu Q; Gu D; Kong D; Xiong X; Su J
Biomed Pharmacother; 2015 Oct; 75():26-32. PubMed ID: 26463628
[TBL] [Abstract][Full Text] [Related]
5. Actively targeted cetuximab conjugated gamma-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cells.
Maya S; Sarmento B; Lakshmanan VK; Menon D; Jayakumar R
J Biomed Nanotechnol; 2014 Aug; 10(8):1416-28. PubMed ID: 25016642
[TBL] [Abstract][Full Text] [Related]
6. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
7. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.
Nagesh PKB; Johnson NR; Boya VKN; Chowdhury P; Othman SF; Khalilzad-Sharghi V; Hafeez BB; Ganju A; Khan S; Behrman SW; Zafar N; Chauhan SC; Jaggi M; Yallapu MM
Colloids Surf B Biointerfaces; 2016 Aug; 144():8-20. PubMed ID: 27058278
[TBL] [Abstract][Full Text] [Related]
8. Improving Cancer Chemoradiotherapy Treatment by Dual Controlled Release of Wortmannin and Docetaxel in Polymeric Nanoparticles.
Au KM; Min Y; Tian X; Zhang L; Perello V; Caster JM; Wang AZ
ACS Nano; 2015 Sep; 9(9):8976-96. PubMed ID: 26267360
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cancer cells' radiation response in the presence of folate conjugated Au@Fe
Mirrahimi M; Hosseini V; Shakeri-Zadeh A; Alamzadeh Z; Kamrava SK; Attaran N; Abed Z; Ghaznavi H; Hosseini Nami SMA
Clin Transl Oncol; 2019 Apr; 21(4):479-488. PubMed ID: 30298468
[TBL] [Abstract][Full Text] [Related]
10. A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model.
Wang X; Li J; Wang Y; Koenig L; Gjyrezi A; Giannakakou P; Shin EH; Tighiouart M; Chen ZG; Nie S; Shin DM
ACS Nano; 2011 Aug; 5(8):6184-94. PubMed ID: 21728341
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitization of TPGS-emulsified docetaxel-loaded poly(lactic-co-glycolic acid) nanoparticles in CNE-1 and A549 cells.
Shi W; Yuan Y; Chu M; Zhao S; Song Q; Mu X; Xu S; Zhang Z; Yang K
J Biomater Appl; 2016 Mar; 30(8):1127-41. PubMed ID: 26608458
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional pH-Responsive Folate Receptor Mediated Polymer Nanoparticles for Drug Delivery.
Cai X; Yang X; Wang F; Zhang C; Sun D; Zhai G
J Biomed Nanotechnol; 2016 Jul; 12(7):1453-62. PubMed ID: 29337470
[TBL] [Abstract][Full Text] [Related]
13. Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
Wang L; Li M; Zhang N
Int J Nanomedicine; 2012; 7():3281-94. PubMed ID: 22802688
[TBL] [Abstract][Full Text] [Related]
14. Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer.
Ganta S; Singh A; Rawal Y; Cacaccio J; Patel NR; Kulkarni P; Ferris CF; Amiji MM; Coleman TP
Drug Deliv; 2016; 23(3):968-80. PubMed ID: 24901206
[TBL] [Abstract][Full Text] [Related]
15. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer.
Werner ME; Cummings ND; Sethi M; Wang EC; Sukumar R; Moore DT; Wang AZ
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):463-468. PubMed ID: 23708084
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells.
Luo Y; Ling Y; Guo W; Pang J; Liu W; Fang Y; Wen X; Wei K; Gao X
J Control Release; 2010 Oct; 147(2):278-88. PubMed ID: 20655966
[TBL] [Abstract][Full Text] [Related]
18. Prolonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticles.
Sunoqrot S; Bugno J; Lantvit D; Burdette JE; Hong S
J Control Release; 2014 Oct; 191():115-22. PubMed ID: 24837188
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
Jiang S; Gong X; Zhao X; Zu Y
Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890
[TBL] [Abstract][Full Text] [Related]
20. Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy.
Sun Y; Zhao Y; Teng S; Hao F; Zhang H; Meng F; Zhao X; Zheng X; Bi Y; Yao Y; Lee RJ; Teng L
Int J Nanomedicine; 2019; 14():135-148. PubMed ID: 30613142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
